govt-to-track-covid-19-vaccine-reactions

Neurologists and cardiologists will be part of the monitoring committees

  • As there are several potential vaccine development for Covid 19 for instance,  
  • AstraZeneca and the University of Oxford recently  reported robust efficacy of up to 90% for the jointly-developed covid-19 vaccine candidate, AZD1222. The announcement paves the way for the British company and its Indian contract manufacturer, the Serum Institute of India (SII), to approach drug regulators in their respective countries for an emergency licensure. 
  • Then , The Russian COVID-19 vaccine candidate Sputnik V has shown an interim efficacy of 91% based on analysing results from nearly 18,000 volunteers, some of whom got the actual vaccine and others a placebo, the Russian Direct Investment Fund (RDIF) the vaccine candidate is also being tested on volunteers in India also Prime Minister asked the State governments to set up steering committees and block-wise task forces to prepare for the distribution of COVID-19 vaccines as and when they are available for disbursal in all these background Govt. set to launch monitoring committees to track vaccine development 

India eyes global front runners in Covid-19 vaccine plan - india news -  Hindustan Times

  • The Health Ministry has written to the State governments and the Union Territory administrations to put in place a robust system for the reporting and gathering of information on the side effects of COVID-19 vaccines once they are rolled out.
  • The Ministry has identified initiatives to strengthen the reporting of Adverse Events Following Immunisation (AEFI)
  • The Ministry has asked that more medical specialists be part of the AEFI committees. COVID-19 vaccination will be given to adults many of whom may have co-morbidities. Events due to pre-existing co-morbidities (stroke/heart attacks, etc) may be reported as AEFI following COVID-19 vaccination. Membership of State AEFI committees should be revised to include neurologists, cardiologists, respiratory medicine specialists who can recognise such events and differentiate them from events related to vaccine and vaccination. Similarly, direction may be issued to districts to include medical specialists (neurologists and cardiologists) in district AEFI committees.